Key result
Brachial-ankle pulse wave velocity was independently associated with the presence of significant coronary artery disease (OR 1.001, p=0.019) but not with disease extent or revascularization.
Why the study?
Does brachial ankle pulse wave velocity (baPWV) predict the presence and extent of significant coronary artery disease or the need for revascularization in patients with suspected CAD?
Observational (n=651)
No
Does brachial ankle pulse wave velocity (baPWV) predict the presence and extent of significant coronary artery disease or the need for revascularization in patients with suspected CAD?
Effect estimate: OR 1.001 (95% CI 1.000-1.002)
p-value: p=0.019
Brachial ankle pulse wave velocity (baPWV) is an independent predictor of the presence of significant coronary artery disease in patients with angina, but it has limited value for predicting the extent of CAD or the need for revascularization.
baPWV may aid CAD presence detection in angina; leaves open utility for extent or revascularization decisions.
BACKGROUND AND OBJECTIVES: Arterial stiffness is well known as an important risk factor for cardiovascular disease. At our institution, we assessed the association between arterial stiffness, as determined by brachial ankle pulse wave velocity (baPWV), and the extent of coronary artery disease (CAD), as detected by conventional coronary angiography (CAG) in patients who visited the outpatient clinic for angina without any previous history of heart disease. In addition, we evaluated if the level of baPWV could predict the revascularization as a clinical outcome. SUBJECTS AND METHODS: On a retrospective basis, we analyzed the data of 651 consecutive patients who had undergone baPWV and elective CAG for suspected CAD between June 2010 and July 2011, at a single cardiovascular center. RESULTS: The baPWV was one of the statistically meaningful predictors of significant CAD (diameter of stenosis >50%) in addition to male gender, age, the level of high density lipoprotein-cholesterol, and hemoglobin A1c in multivariate analysis. However, baPWV was not the significant predictor of revascularization. When the extent of CAD was classified into following 4 groups; no significant CAD, 1-, 2- and 3-vessel disease, there was significant difference of baPWV between the significant and non-significant CAD group, but there was no difference of baPWV among the 3 significant CAD groups, although there was a trend toward the positive correlation. CONCLUSION: Although baPWV was an independent predictor of significant CAD, it was neither associated significantly with the extent of CAD nor with the risk of revascularization. Therefore, baPWV has a limited value for portending the severity of CAD in patients with chest pain.
No takes yet. Share an insight, caveat, or question.
Chae et al. (2013) conducted an observational in Suspected Coronary Artery Disease (n=651). Brachial-ankle pulse wave velocity (baPWV) was evaluated on Presence of significant coronary artery disease (>50% luminal narrowing) (OR 1.001, 95% CI 1.000-1.002, p=0.019). Brachial-ankle pulse wave velocity was independently associated with the presence of significant coronary artery disease (OR 1.001, p=0.019) but not with disease extent or revascularization.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: